Comparison of fatty meal and intravenous cholecystokinin infusion for gallbladder ejection fraction

Gerbail T. Krishnamurthy, Paul Brown

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Gallbladder ejection fraction (GBEF) measured with a fatty meal (half-and-half milk) was compared with that measured with 2 equal sequential intravenous infusions of cholecystokinin (CCK-8) in a paired study of healthy subjects. Methods: GBEF was measured by 99mTc-hepatic iminodiacetic acid cholescintigraphy in 13 healthy subjects. Each subject received 2 sequential doses of CCK-8 (3 ng/kg/min for 10 min) on day 1, followed by, on day 2, a 240-mL (8 oz) fatty meal (half-and-half milk) per 70 kg of body weight. Results: The mean ± SD GBEF of 53.6% ± 20.2% with fatty meal was significantly lower than the mean of 75.8% ± 16.3% (P <0.01) with the first dose of CCK-8 and 71.3% ± 17.4% (P <0.05) with the second dose. Fatty meal GBEF varied widely, from 23.5% to 91.8%. Percentile rankings of the fatty meal GBEF were determined as the preferred methodology for reporting results. Latent and ejection periods were significantly longer with fatty meal than with either dose of CCK-8. Conclusion: GBEF measured with fatty meal can serve as an alternative method to intravenous injection of CCK-8 when the hormone is no longer available for clinical use. The measurement of GBEF with fatty meal requires careful attention to the details of the meal and the measurement time sequence.

Original languageEnglish (US)
Pages (from-to)1603-1610
Number of pages8
JournalJournal of Nuclear Medicine
Volume43
Issue number12
StatePublished - Dec 1 2002

Fingerprint

Cholecystokinin
Gallbladder
Intravenous Infusions
Meals
Sincalide
Healthy Volunteers
Milk
Intravenous Injections
Body Weight
Hormones
Liver

Keywords

  • Cholecystokinin
  • Fatty meal
  • Gallbladder ejection fraction
  • Hepatobiliary imaging

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Comparison of fatty meal and intravenous cholecystokinin infusion for gallbladder ejection fraction. / Krishnamurthy, Gerbail T.; Brown, Paul.

In: Journal of Nuclear Medicine, Vol. 43, No. 12, 01.12.2002, p. 1603-1610.

Research output: Contribution to journalArticle

Krishnamurthy, Gerbail T. ; Brown, Paul. / Comparison of fatty meal and intravenous cholecystokinin infusion for gallbladder ejection fraction. In: Journal of Nuclear Medicine. 2002 ; Vol. 43, No. 12. pp. 1603-1610.
@article{c1c8d5ed509e4108ad367e2ce1b78012,
title = "Comparison of fatty meal and intravenous cholecystokinin infusion for gallbladder ejection fraction",
abstract = "Gallbladder ejection fraction (GBEF) measured with a fatty meal (half-and-half milk) was compared with that measured with 2 equal sequential intravenous infusions of cholecystokinin (CCK-8) in a paired study of healthy subjects. Methods: GBEF was measured by 99mTc-hepatic iminodiacetic acid cholescintigraphy in 13 healthy subjects. Each subject received 2 sequential doses of CCK-8 (3 ng/kg/min for 10 min) on day 1, followed by, on day 2, a 240-mL (8 oz) fatty meal (half-and-half milk) per 70 kg of body weight. Results: The mean ± SD GBEF of 53.6{\%} ± 20.2{\%} with fatty meal was significantly lower than the mean of 75.8{\%} ± 16.3{\%} (P <0.01) with the first dose of CCK-8 and 71.3{\%} ± 17.4{\%} (P <0.05) with the second dose. Fatty meal GBEF varied widely, from 23.5{\%} to 91.8{\%}. Percentile rankings of the fatty meal GBEF were determined as the preferred methodology for reporting results. Latent and ejection periods were significantly longer with fatty meal than with either dose of CCK-8. Conclusion: GBEF measured with fatty meal can serve as an alternative method to intravenous injection of CCK-8 when the hormone is no longer available for clinical use. The measurement of GBEF with fatty meal requires careful attention to the details of the meal and the measurement time sequence.",
keywords = "Cholecystokinin, Fatty meal, Gallbladder ejection fraction, Hepatobiliary imaging",
author = "Krishnamurthy, {Gerbail T.} and Paul Brown",
year = "2002",
month = "12",
day = "1",
language = "English (US)",
volume = "43",
pages = "1603--1610",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "12",

}

TY - JOUR

T1 - Comparison of fatty meal and intravenous cholecystokinin infusion for gallbladder ejection fraction

AU - Krishnamurthy, Gerbail T.

AU - Brown, Paul

PY - 2002/12/1

Y1 - 2002/12/1

N2 - Gallbladder ejection fraction (GBEF) measured with a fatty meal (half-and-half milk) was compared with that measured with 2 equal sequential intravenous infusions of cholecystokinin (CCK-8) in a paired study of healthy subjects. Methods: GBEF was measured by 99mTc-hepatic iminodiacetic acid cholescintigraphy in 13 healthy subjects. Each subject received 2 sequential doses of CCK-8 (3 ng/kg/min for 10 min) on day 1, followed by, on day 2, a 240-mL (8 oz) fatty meal (half-and-half milk) per 70 kg of body weight. Results: The mean ± SD GBEF of 53.6% ± 20.2% with fatty meal was significantly lower than the mean of 75.8% ± 16.3% (P <0.01) with the first dose of CCK-8 and 71.3% ± 17.4% (P <0.05) with the second dose. Fatty meal GBEF varied widely, from 23.5% to 91.8%. Percentile rankings of the fatty meal GBEF were determined as the preferred methodology for reporting results. Latent and ejection periods were significantly longer with fatty meal than with either dose of CCK-8. Conclusion: GBEF measured with fatty meal can serve as an alternative method to intravenous injection of CCK-8 when the hormone is no longer available for clinical use. The measurement of GBEF with fatty meal requires careful attention to the details of the meal and the measurement time sequence.

AB - Gallbladder ejection fraction (GBEF) measured with a fatty meal (half-and-half milk) was compared with that measured with 2 equal sequential intravenous infusions of cholecystokinin (CCK-8) in a paired study of healthy subjects. Methods: GBEF was measured by 99mTc-hepatic iminodiacetic acid cholescintigraphy in 13 healthy subjects. Each subject received 2 sequential doses of CCK-8 (3 ng/kg/min for 10 min) on day 1, followed by, on day 2, a 240-mL (8 oz) fatty meal (half-and-half milk) per 70 kg of body weight. Results: The mean ± SD GBEF of 53.6% ± 20.2% with fatty meal was significantly lower than the mean of 75.8% ± 16.3% (P <0.01) with the first dose of CCK-8 and 71.3% ± 17.4% (P <0.05) with the second dose. Fatty meal GBEF varied widely, from 23.5% to 91.8%. Percentile rankings of the fatty meal GBEF were determined as the preferred methodology for reporting results. Latent and ejection periods were significantly longer with fatty meal than with either dose of CCK-8. Conclusion: GBEF measured with fatty meal can serve as an alternative method to intravenous injection of CCK-8 when the hormone is no longer available for clinical use. The measurement of GBEF with fatty meal requires careful attention to the details of the meal and the measurement time sequence.

KW - Cholecystokinin

KW - Fatty meal

KW - Gallbladder ejection fraction

KW - Hepatobiliary imaging

UR - http://www.scopus.com/inward/record.url?scp=0036897539&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036897539&partnerID=8YFLogxK

M3 - Article

C2 - 12468508

AN - SCOPUS:0036897539

VL - 43

SP - 1603

EP - 1610

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 12

ER -